Quantcast

Keystone Today

Wednesday, November 6, 2024

FDA conducted second highest number of inspections on Biologics companies in Pennsylvania during Q4 2023

Webp 2ezm6a5laa3vullezt9gk0ym96qi

Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website

Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website

In the fourth quarter of 2023, 11 Biologics companies received 11 FDA inspections in Pennsylvania, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Pennsylvania, equalling 19.6% of all inspections in the fourth quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in Pennsylvania During Q4 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring4----
Blood and Blood Products11----
Compliance: Devices72--
Drug Quality Assurance--2--
Food Composition, Standards, Labeling and Econ9--1
Foodborne Biological Hazards1531
Human Cellular, Tissue, and Gene Therapies3----
Monitoring of Marketed Animal Drugs, Feed, and Devices81--
Postmarket Assurance: Devices3----
Technical Assistance: Food and Cosmetics3----

MORE NEWS